Last reviewed · How we verify
NCT03244137
Effects of Pulmonary Rehabilitation on Cognitive Function in Patients With Severe to Very Severe Chronic Obstructive Pulmonary Disease
trial testing Pulmonary rehabilitation in Chronic Obstructive Pulmonary Disease in 56 participants. Completed in 1 December 2019.
1 December 2019
Quick facts
| Lead sponsor | ADIR Association |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 56 |
| Start date | 4 September 2017 |
| Primary completion | 1 December 2019 |
| Estimated completion | 1 December 2019 |
| Sites | 2 locations across France |
Drugs / interventions tested
- Pulmonary rehabilitation
Conditions studied
- Chronic Obstructive Pulmonary Disease — all drugs for Chronic Obstructive Pulmonary Disease →
Sponsor
ADIR Association
Who can join
18 and older, any sex, with Chronic Obstructive Pulmonary Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Chronic obstructive pulmonary disease is a leading cause of mortality worldwide. It is a systemic disease which includes pulmonary, cardiac, muscular, digestive and cognitive impairments. Pulmonary rehabilitation is a symptomatic treatment to reduce dyspnea and functional incapacity. However, it effects on cognitive dysfunction are not well known. The aim of this study is to assess the effects of a comprehensive pulmonary rehabilitation program on cognitive dysfunction in patients with severe to very severe chronic obstructive pulmonary disease using the Montreal Cognitive Assessment tool.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Mid-Term Effects of Pulmonary Rehabilitation on Cognitive Function in People with Severe Chronic Obstructive Pulmonary Disease.
Bonnevie T, Medrinal C, Combret Y, Debeaumont D, et al · · 2020 · cited 12× · PMID 32546999 · DOI 10.2147/copd.s249409
Verify or expand the search:
- PubMed search for NCT03244137
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Pulmonary rehabilitation
Trials testing the same drug.
- NCT07088185 — Pulmonary Outcomes on Patients With Lung Fibrosis · NA · active not recruiting
- NCT06522724 — Education Impact on Rehabilitation of Hospitalized Patients With Pneumonia and COVID-19 · NA · completed
- NCT06366113 — Time of Exercise Re-training With Chronic Obstructive Pulmonary Disease (COPD) · NA · recruiting
- NCT06028711 — Education Impact on Rehabilitation of Hospitalized Patients with Chronic Obstructive Pulmonary Disease. · NA · completed
- NCT06051136 — Early Versus Delayed Rehabilitation Intervention in Patients With Lung Cancer · NA · active not recruiting
Other recruiting trials for Chronic Obstructive Pulmonary Disease
Currently open trials in the same condition.
- NCT06749262 — Inclined Versus Standard Exercise for COPD Patients · NA · recruiting
- NCT07406659 — Different Inspiratory Muscle Trainings in Patients With COPD · NA · recruiting
- NCT07051707 — Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD · NA · recruiting
- NCT07418736 — A Phase II Study of CM326 in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease · Phase 2 · recruiting
- NCT07069829 — Study of Clinical and Patient-reported Outcomes in Adults With Moderate to Severe COPD Treated With Breztri/Trixeo · recruiting
Other ADIR Association trials
Trials by the same sponsor.
- NCT06956742 — Intermittent Intrapulmonary Deflation and Dyspnea Following Exercise in People With Chronic Obstructive Pulmonary Diseas · NA · recruiting
- NCT06703359 — Predictive Properties of the 6-Minute Stepper Test for Mortality in COPD · recruiting
- NCT06079151 — Hemodynamic Effect of Nasal High-flow in Patients Suspected or Followed for a Precapillary Pulmonary Hypertension · NA · recruiting
- NCT06182956 — NIV Versus HFO for Acute Exacerbations of Interstitial Lung Diseases · NA · not yet recruiting
- NCT05372926 — Physiological Effects of HFNC During Exercise in Patients With Fibrosing Interstitial Lung Diseases · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03244137 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by ADIR Association
- Last refreshed: 7 January 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03244137.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing